Humana (NYSE:HUM) Price Target Cut to $176.00 by Analysts at Barclays

Humana (NYSE:HUM) had its price objective decreased by Barclays from $245.00 to $176.00 in a research note released on Tuesday, Marketbeat reports. Barclays currently has an equal weight rating on the insurance provider’s stock.

A number of other brokerages have also commented on HUM. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $344.00 price objective on shares of Humana in a report on Tuesday, January 6th. JPMorgan Chase & Co. decreased their price target on shares of Humana from $274.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday, February 13th. Zacks Research cut shares of Humana from a “hold” rating to a “strong sell” rating in a research note on Thursday, January 1st. Wells Fargo & Company decreased their target price on shares of Humana from $290.00 to $206.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 18th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Humana in a report on Friday, December 12th. Seven analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, Humana has an average rating of “Hold” and a consensus price target of $225.48.

Humana Stock Performance

Shares of NYSE HUM traded up $3.22 during midday trading on Tuesday, hitting $177.86. 357,349 shares of the company’s stock were exchanged, compared to its average volume of 2,241,356. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $21.45 billion, a PE ratio of 18.09, a price-to-earnings-growth ratio of 1.94 and a beta of 0.44. Humana has a 12 month low of $169.61 and a 12 month high of $315.35. The company’s 50 day moving average price is $233.89 and its 200 day moving average price is $257.59.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating the consensus estimate of ($4.01) by $0.05. The firm had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company’s quarterly revenue was up 11.3% on a year-over-year basis. During the same period in the previous year, the company earned ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, analysts predict that Humana will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, March 27th. Humana’s payout ratio is 36.05%.

Institutional Investors Weigh In On Humana

Large investors have recently modified their holdings of the company. Montag A & Associates Inc. boosted its stake in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC boosted its position in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the fourth quarter valued at approximately $27,000. Rosenberg Matthew Hamilton grew its holdings in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of Humana in the 2nd quarter worth approximately $32,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.